Table 3.
Comparison of the clinical characteristics between control and cases
Control with high risk group | High risk group with Preeclampsia | Control group with Preeclampsia | ||||
---|---|---|---|---|---|---|
|
||||||
t | P | t | P | t | P | |
BMI (kg/m2) | 4.626 | < 0.001* | 3.23 | 0.003** | 1.395 | 0.16 |
Gestational age (weeks) | 0.698 | 0.48 | 2.85 | < 0.05** | 2.15 | 0.06 |
Hematocrit (%) | 0.31 | 0.75 | 1.98 | 0.096 | 2.30 | 0.06 |
Platelet count (10^3/μl) | 3.964 | < 0.001* | 3.741 | < 0.001* | 7.705 | < 0.001* |
sATP (mmHg) | 2.63 | 0.01** | 10.07 | < 0.001* | 12.64 | < 0.001* |
dATP (mmHg) | 2.16 | 0.033** | 7.66 | < 0.001* | 9.762 | < 0.001* |
Serum albumin (g/l) | 4.04 | < 0.001* | 3.94 | < 0.001* | 7.96 | < 0.001* |
erum copper (mg/L) | 2.16 | 0.03** | 2.20 | 0.06 | 4.36 | < 0.001* |
Serum manganese (mg/L) | 4.05 | < 0.001* | 0.35 | 0.72 | 3.70 | < 0.001* |
Serum zinc (mg/L) | 2.36 | 0.02** | 2.37 | 0.04** | 4.74 | < 0.001* |
P < 0.001;
P < 0.05.